Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The β‐amyloid (Aβ) peptide has previously been shown to enhance phenylephrine or endothelin‐1 induced constriction of aortic rings in vitro. The characteristics of Aβ vasoactivity (dose, fragment length, timing) suggest that the mechanism is distinct from Aβ cytotoxicity. To identify which properties of Aβ determine its biological activity on vessels, we investigated a number of Aβ analogues and fragments, individually and in combination, including those that are known to be associated with Alzheimer's disease (Aβ 1–42) and hereditary cerebral hemorrhage with amyloidosis – Dutch type (Aβ(22Q)1–40). The vasoactivity appears to be related to the conformation adopted by the peptide in solution. The β‐pleated sheet rich Aβ 1–42 and Aβ(22Q)1–40 were each less vasoactive than the mainly random coil wild type Aβ 1–40. However, the most vasoactive Aβ peptides were combinations which contain mixtures of random coil and β‐sheet structure. The finding that peptides containing low or high levels of β‐pleated conformation are less vasoactive than those containing intermediate amounts of this structural motif allows us to propose the existence of a transitional form between random coil and β‐pleated that is the vasoactive species of Aβ. This is the first time that Aβ conformational intermediates have been identified and a biological activity associated with them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
Self-citation
Cited by
Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
Lansbury, P. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3342 · Cited by 553
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454
Merlini, M., Meyer, E. P., Ulmann-Schuler, A., & Nitsch, R. M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0834-y · Cited by 225
Inhibition of Angiogenesis by Aβ Peptides
Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., DelleDonne, A., Patel, N., Obregon, D. F., et al. (2004) · Angiogenesis · doi:10.1023/b:agen.0000037335.17717.bf · Cited by 148
Self-citationRoeben, B., the TREND study team, Maetzler, W., Vanmechelen, E., Schulte, C., Heinzel, S., Stellos, K., Godau, J., Huber, H., Brockmann, K., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150575 · Cited by 19
Metadata
- Authors
- Crawford, F., Soto, C., Suo, Z., Fang, C., Parker, T., Sawar, A., Frangione, B., & Mullan, M.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1998-10-09
- Volume
- 436
- Issue
- 3
- Pages
- 445-448
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2081675055
- Cited by
- 26
- References
- 2
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate. https://app.cochat.ai/papers/10.1016/s0014-5793(98)01170-3
- The paper
- Crawford, F., Soto, C., Suo, Z., Fang, C., Parker, T., Sawar, A., Frangione, B., & Mullan, M. (1998). Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate. FEBS Letters. https://doi.org/10.1016/s0014-5793(98)01170-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.